Transgene (XPAR:TNG) Machinery, Furniture, Equipment : €1.75 Mil (As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Transgene Machinery, Furniture, Equipment?

Transgene's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2023 was €1.75 Mil.

Transgene's quarterly Machinery, Furniture, Equipment declined from Dec. 2022 (€1.72 Mil) to Jun. 2023 (€1.71 Mil) but then increased from Jun. 2023 (€1.71 Mil) to Dec. 2023 (€1.75 Mil).

Transgene's annual Machinery, Furniture, Equipment increased from Dec. 2021 (€1.67 Mil) to Dec. 2022 (€1.72 Mil) and increased from Dec. 2022 (€1.72 Mil) to Dec. 2023 (€1.75 Mil).

Transgene Machinery, Furniture, Equipment Historical Data

The historical data trend for Transgene's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgene Machinery, Furniture, Equipment Chart

Transgene Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

1.66

1.65

1.67

1.72

1.75

Transgene Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															1.67	1.70	1.72	1.71	1.75

Transgene Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Transgene (XPAR:TNG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene SA (XPAR:TNG) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

TGNA:Germany

Address

400 Boulevard Gonthier d’Andernach, Parc d’Innovation - CS80166, Illkirch-Graffenstaden, FRA, 67400

Website

https://www.transgene.fr

Transgene SA is a biotechnology company. It is involved in the business of discovering and focusing immune-targeted therapies for the treatment of cancer and infectious diseases. The company's clinical-stage programs are TG4010 for non-small cell lung cancer and Pexa-vec for liver cancer. Its product pipeline includes TG4001, TG1050, TG6002 etc. It is engaged in clinical research and development of therapeutic vaccines and immunotherapeutic products.

Transgene (XPAR:TNG) Headlines

No Headlines